Criteria of drug-induced liver disorders. Report of an international consensus meeting.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Journal of Hepatology

• Publication date

  1990-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0168-8278(90)90124-APMID 2254635
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Drug-induced cutaneous photosensitivity. Results of a consensus meeting].

  1989cited by this paper
• [Drug-induced renal insufficiency. Results of consensus meetings].

  1989cited by this paper
• [Interstitial pneumopathies: criteria of drug side-effects. Results of consensus meetings].

  1989cited by this paper
• Consensus meetings on: Causality assessment of drug-induced liver injury

  1988cited by this paper
• Causality assessment of drug-induced liver injury. Hepatology Working Group.

  1988cited by this paper
• [Drug-induced hemolytic anemia. Results of consensus conferences].

  1988cited by this paper
• [How to diagnose a cutaneous complication of a drug. Application to vascular purpura].

  1987cited by this paper
• [Criteria for assessing granulocytic or platelet cytopenia caused by drugs. Results of consensus meetings].

  1987cited by this paper
• [Consensus conference on definitions in drug monitoring].

  1987cited by this paper
• [Criteria of imputation of acute hepatitis to a drug. Results of consensus meetings].

  1987cited by this paper

• Beyond the Pump: The Evolving Molecular Landscape of Intrahepatic Cholestasis

  2026cites this paper
• In Vitro-In Silico Models to Elucidate Mechanisms of Bile Acid Disposition and Cellular Aerobics in Human Hepatocytes

  2025cites this paper
• Natural History of Idiosyncratic Drug‐Induced Liver Injury and Prognostic Models

  2025cites this paper
• Model of baseline clinicopathological features predicts non-resolution of drug-induced liver injury at 6 months

  2025influential citation
• The Straw That Broke the Camel’s Back: Amoxicillin-Clavulanate Unraveling Autoimmune Hepatitis in a Previously Asymptomatic Female

  2025influential citation
• Establishment and validation of a predictive nomogram for voriconazole-associated liver injury in lung transplant patients

  2025cites this paper
• Probable Cinnamon-Induced Mixed Hepatocellular-Cholestatic Liver Injury in a Young Woman: A Case Report

  2025influential citation
• The incidence of chronic drug-induced liver injury: a systematic review and meta-analysis

  2025cites this paper
• Soft‐Drug‐Inspired MnSTF Nano‐Adjuvant for Safe and Synergistic cGAS–STING Activation in Tumor Immunotherapy

  2025cites this paper
• Genetic and clinical risk factors for anti-tuberculosis drug-induced liver injury: insights from a prospective cohort study in central Ethiopia

  2025cites this paper
• Genetic Variants of GBP4: Reduced Risks for Drug‐Induced Acute Liver Failure in Non‐Finnish European Population

  2025cites this paper
• CYP2E1 POLYMORPHISMS AND SUSCEPTIBILITY TO ANTI-TUBERCULOSIS DRUG-INDUCED HEPATOTOXICITY IN INDONESIA POPULATION

  2025cites this paper
• Drug metabolizing enzymes and transporters, and their roles for the development of drug-induced liver injury

  2025cites this paper
• Development of a Predictive Model for Classifying Immune Checkpoint Inhibitor‐Induced Liver Injury Types

  2025cites this paper
• Management of asymptomatic patients with abnormal liver function tests.

  2025cites this paper
• Fever following Treatment with Atezolizumab plus Bevacizumab Predicts Liver Injury in Patients with Unresectable Hepatocellular Carcinoma: A Prospective Observational Analysis

  2025cites this paper
• Identification of Independent Prognostic Factors and Establishment of Risk Classification Model in Patients with Liver Injury

  2025cites this paper
• Drug‐Induced Liver Injury Associated With Turmeric and Black Pepper Based Dietary Supplements Consumption: A Case Report

  2025cites this paper
• Safety of herbal medicines in Korean medicine clinics in Republic of Korea: A nationwide retrospective longitudinal cohort study.

  2025cites this paper
• Artificial intelligence as a promising tool for predicting drug-induced liver injury in patients receiving tuberculosis medication: A systematic review

  2025cites this paper
• Identification of Genetic Risk Factors Associated With Herbal and Dietary Supplement–Induced Acute Liver Failure Using Whole Exome Sequencing Analysis

  2025cites this paper
• Incidence of and risk factors for side effects associated with antibiotic treatment for pneumonia.

  2025cites this paper
• Relationship between urinary phthalate metabolites and liver function indicators in the elderly in Northeast China.

  2025cites this paper
• Drug‐Induced Liver Injury Associated With Emerging Cancer Therapies

  2025cites this paper
• Incidence, Clinical Features, Associated Factors and Outcomes of Intensive Phase Antituberculosis Drug Induced Liver Injury Among Patients With Tuberculosis at a Tertiary Care Hospital in Nepal: A Descriptive Cross‐Sectional Study

  2025cites this paper
• Inhibitory Effects of Alkaloids on OATP1B1 In Vitro and In Vivo: Prediction for Food/Herb-Drug Interactions and Hepatoprotective Effects Based on Structure-Activity Relationships.

  2025cites this paper
• Subphenotypes and the De Ritis ratio for mortality risk stratification in sepsis-associated acute liver injury: a retrospective cohort study

  2025cites this paper
• Validation of the revised electronic version of RUCAM for diagnosis of DILI in Chinese patients

  2024cites this paper
• Novel clinical phenotypes, drug categorization, and outcome prediction in drug-induced cholestasis: Analysis of a database of 432 patients developed by literature review and machine learning support.

  2024cites this paper
• Liver Injury in People With HIV on Antituberculosis and/or Antiretroviral Therapy—Assessing Causality Using the Updated Roussel Uclaf Causality Assessment Method

  2024cites this paper
• Rechallenge in idiosyncratic drug-induced liver injury: an analysis of cases in two large prospective registries according to existing definitions.

  2024cites this paper
• Incidence of amoxycillin-clavulanic acid associated hepatotoxicity in an Australian children's hospital.

  2024cites this paper
• A Review on Drug-Induced Hepatotoxicity

  2024cites this paper
• The hepatoprotective effect of 4-phenyltetrahydroquinolines on carbon tetrachloride induced hepatotoxicity in rats through autophagy inhibition

  2024cites this paper
• Liver Dysfunction in Hyperthyroidism

  2024cites this paper
• Drug-induced liver injury related to avacopan therapy.

  2024cites this paper
• Methods for causality assessment of idiosyncratic drug‐induced liver injury

  2024cites this paper
• Development of a Modular miRNA-Responsive Biosensor for Organ-Specific Evaluation of Liver Injury

  2024cites this paper
• Retrospective Evaluation of Patients with Toxic Liver Disease and Fungal Intoxication: A University Hospital Experience

  2024influential citation
• Clinical guidance for cannabidiol‐associated hepatotoxicity: A narrative review

  2024cites this paper
• Clinical stratification of 1318 Primary Sjögren's Syndrome patients.

  2024cites this paper
• Propensity score matching-based analysis of the effect of corticosteroids in treating severe drug-induced liver injury.

  2024cites this paper
• Protective effects of 17-β-estradiol on liver injury: The role of TLR4 signaling pathway and inflammatory response.

  2024cites this paper
• Diagnostic guide for immune checkpoint inhibitor‐induced liver injury

  2024cites this paper
• [Adverse effects of the tezacaftor/ivacaftor/elexacaftor combination that may lead to discontinuation: About a series of 10 cases].

  2024cites this paper
• Biomarkers of Hepatic Toxicity: An Overview

  2024cites this paper
• Polymorphism of CYP3A4*18 is associated with anti-tuberculosis drug-induced hepatotoxicity.

  2024cites this paper
• Phytotherapy-Induced Hepatocytotoxicity: A Case Report

  2024cites this paper
• Investigation of the Role of Chemical Analysis in Causality Assessment of Herbal and Dietary Supplement-Induced Liver Injury

  2024cites this paper
• Atypical Intrahepatic Cholestasis of Pregnancy: A Red Herring

  2024cites this paper
• Primary Biliary Cholangitis With Pulmonary Manifestations and Concurrent Enterococcus Pneumonia: A Diagnostic Challenge Resembling Sarcoidosis or Silicosis

  2024cites this paper
• Elevated liver enzymes in a German tertiary-care hospital: Distribution, diagnostic steps and diagnosis groups

  2023cites this paper
• Pengembangan Metode PCR Multipleks untuk Analisis Genotipe Null Gen GSTM1/GSTT1 pada Pasien Tuberkulosis

  2023cites this paper
• Antituberculosis drug-induced non-blistering systemic severe reactions: A 10-year (2012-2022) literature review.

  2023cites this paper
• Drug-induced cholestasis: causative agents and challenges in diagnosis and management

  2023cites this paper
• AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury: also useful for hepatobiliary surgeons

  2023cites this paper
• Association of BMI with mortality in drug-induced liver injury

  2023cites this paper
• Prior drug allergies are associated with worse outcome in patients with idiosyncratic drug-induced liver injury: A machine learning approach for risk stratification.

  2023cites this paper
• Hepatic/Renal Safety Evaluation of Cheongsimyeonja-tang (Qīngxīn Liánzǎo Tāng), Dodam-tang (Táodàn Tāng), Hyeolbuchukso-tang (Xuè Fǔ Zhú Yū Tāng), and Boshiniknai-tang (Bǔ Shèn Yì Nǎo Tāng) for Cerebrovascular Diseases: A Retrospective Study

  2023cites this paper
• Microphysiological Models for Mechanistic-Based Prediction of Idiosyncratic DILI

  2023cites this paper
• The Development and Validation of a Predictive Model for Voriconazole-Related Liver Injury in Hospitalized Patients in China

  2023cites this paper
• Industry Review of Best Practices for Risk Management of Drug-Induced Liver Injury from Development to Real-World Use

  2023cites this paper
• Machine-learning-based adverse drug event prediction from observational health data: a review.

  2023cites this paper
• A narrative review of the role of exosomes and caveolin-1 in liver diseases and cancer.

  2023cites this paper
• Amoxicillin-Clavulanate Induced Liver Injury in a Young Female

  2023cites this paper
• Clinical presentation, causative drugs and outcome of patients with autoimmune features in two prospective DILI registries

  2023cites this paper
• Antitubercular drugs induced liver injury: an updated insight into molecular mechanisms

  2023cites this paper
• The clinical toxicology of ketamine

  2023cites this paper
• Clinic-radiomics model using liver magnetic resonance imaging helps predict chronicity of drug-induced liver injury

  2023cites this paper
• Holistic Metabolomic Profiling of Chronic versus Acute Drug-induced Liver Injury

  2023cites this paper
• Prednisolone therapy accelerates recovery of severe drug-induced liver injury: A prospective, randomized controlled study

  2023cites this paper
• Case 4-2023: A 56-Year-Old Man with Abnormal Results on Liver Testing.

  2023cites this paper
• A Unique In Vitro Assay to Investigate ABCB4 Transport Function

  2023influential citation
• Idiosyncratic DILI and RUCAM under One Hat: The Global View

  2023cites this paper
• Polygoni Multiflori Radix interferes with bile acid metabolism homeostasis by inhibiting Fxr transcription, leading to cholestasis

  2023cites this paper
• Overview of diagnostic laboratory tests and diagnostic criteria for liver injury caused by Kampo medicine

  2023cites this paper
• Liver injury from direct oral anticoagulants

  2023cites this paper
• Rosiglitazone induces hepatocyte injury by increasing DCA accumulation through OATP1A4 inhibiting in mice

  2023cites this paper
• Anti-tuberculosis treatment-induced hepatotoxicity in a post-operative setting

  2023cites this paper
• Impact of SLCO1B1*5 on Flucloxacillin and Co-Amoxiclav–Related Liver Injury

  2022cites this paper
• Identifying olanzapine induced liver injury in the setting of acute hepatitis C: A case report

  2022cites this paper
• Toward Kidney-Specific Causality Assessment Tool.

  2022cites this paper
• 3,3',5-triiodo-l-thyronine inhibits drug-induced liver injury through suppression of PPAR-α as revealed by network pharmacology and biological experimental verification.

  2022cites this paper
• Long-term ketamine infusion-induced cholestatic liver injury in COVID-19-associated acute respiratory distress syndrome

  2022cites this paper
• Drug‐Induced Liver Injury: A Mexican View

  2022cites this paper
• Toxic hepatitis-associated aplastic anaemia after dual homeopathic remedies and Gymnema sylvestre use

  2022cites this paper
• Incidence and risk factors of drug‐induced liver injury

  2022cites this paper
• Quand évoquer une hépatite médicamenteuse chez l’enfant ?

  2022cites this paper
• Efectos adversos severos de los estabilizadores del ánimo: revisión de la literatura

  2022cites this paper
• Liver Function Derangement in Patients with Severe Fever and Thrombocytopenia Syndrome

  2022cites this paper
• Clarify the potential cholestatic hepatotoxicity components from Chinese Herb Medicine and metabolism's role via hBSEP vesicles and S9/hBSEP vesicles.

  2022cites this paper
• Toxic hepatitis case with prolonged jaundice due to Favipiravir

  2022cites this paper
• Single Nucleotide Polymorphism of Genes Associated with Metabolic Fatty Liver Disease

  2022cites this paper
• Clinical and Genetic Risk Factors for Drug-Induced Liver Injury Associated with Anti-Tuberculosis Treatment—A Study from Patients of Portuguese Health Centers

  2022cites this paper
• Liver Damage and microRNAs: An Update

  2022cites this paper
• Potential benefit and lack of serious risk from corticosteroids in drug‐induced liver injury: An international, multicentre, propensity score‐matched analysis

  2022cites this paper
• Role of Hepatocyte Transporters in Drug-Induced Liver Injury (DILI)—In Vitro Testing

  2022cites this paper
• Drug-Induced Liver Injury: A Literature Review

  2022cites this paper
• Long-term traditional Chinese medicine–induced liver cirrhosis

  2022cites this paper
• Inflammatory bowel disease type influences development of elevated liver enzymes

  2022cites this paper